Lilly signs another AI deal, this one for obesity
In its latest push into artificial intelligence, Lilly has signed a deal with a California-based biotech to discover new obesity targets in humans. Fauna Bio says it will give Lilly access to its AI platform to support preclinical drug discovery efforts.... Read More